Ligand's (LGND) Drug-Developing Technologies Holds Potential

Published on November 26, 2021

Ligand's (LGND) Captisol technology is a key driver for its topline. The company plans to spin off another potential technology platform, OmniAb, into a separate company.

Continue reading on website
Other news

G-III Apparel (GIII) Queued Up for Q3 Earnings: What to Expect

November 26, 2021
G-III Apparel's (GIII) third-quarter fiscal 2022 results are likely to reflect gains from its brand strength and digital business.

ViacomCBS (VIAC) Buys Majority Stake in Disney Properties

November 26, 2021
ViacomCBS' (VIAC) acquisition of Fox TeleColombia and Estudios TeleMexico will help it cater to higher demand for Spanish content in Latin America.